☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Mutations
Vertex's Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA's Approval in Children Aged 6 to 11 with Ce...
June 10, 2021
Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations
March 16, 2021
Janssen Reports Results of Amivantamab in P-I CHRYSALIS Study for Metastatic or Unresectable NSCLC and EGFR Exon 20 Insertion Muta...
January 29, 2021
Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains
August 20, 2020
The US FDA Approves Guardant360 CDx as the First Liquid Biopsy NGS Assay to Identify EGFR Mutations in Non-Small Cell Lung Cancer
August 10, 2020
Vertex Receives EU's MAA for Symkevi (tezacaftor/ivacaftor) + Kalydeco (Ivacaftor) to Treat Patients with CF aged ≥12yrs. with Mut...
November 2, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.